Urinary arsenic profiles and the risks of cancer mortality: A population-based 20-year follow-up study in arseniasis-endemic areas in Taiwan

Environmental Research

Volumn 122, Issue , 2013, Pages 25-30

  Chung, Chi Jung ^a,b   Huang, Ya Li ^c   Huang, Yung Kai ^d   Wu, Meei Maan ^d   Chen, Shu Yuan ^e   Hsueh, Yu Mei ^c,d   Chen, Chien Jen ^f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Cancer mortality; Cumulative arsenic exposure; Standardized mortality ratio; Urinary arsenic profile

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; WELL WATER;

ARSENIC; BIOMARKER; CANCER; DOSE-RESPONSE RELATIONSHIP; ENDEMIC SPECIES; HEALTH RISK; MORTALITY; POLLUTION EXPOSURE; PUBLIC HEALTH; RESIDENT POPULATION; RISK ASSESSMENT; SPATIOTEMPORAL ANALYSIS;

ADULT; ARSENIC POISONING; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLADDER CANCER; CANCER MORTALITY; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; ENDEMIC DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; FOLLOW UP; HEALTH HAZARD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; METHYLATION; NEOPLASM; POPULATION BASED CASE CONTROL STUDY; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RISK FACTOR; RURAL POPULATION; SECONDARY METHYLATION INDEX; STANDARDIZED MORTALITY RATIO; TAIWAN; URINALYSIS;

ARSENIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; SMOKING; TAIWAN;

TAIWAN;

EID: 84875075514     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2012.11.007     Document Type: Article

References (36)

1. Andreae M.O. Determination of arsenic species in natural waters. Anal. Chem. 1977, 49:820-823.
2. Argos M., Kalra T., Rathouz P.J., Chen Y., Pierce B., Parvez F., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Slavkovich V., van Geen A., Graziano J., Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet 2010, 376:252-258.
3. Breslow N.E., Day N.E. Stat. Methods Cancer Res. 2011, II. The analysis of cohort studies. International Agency for Research on Cancer, Lyon, p. 120.
4. Buchet J.P., Lison D. Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic. Int. Arch. Occup. Environ. Health 1998, 71:125-130.
5. Chen C.J., Chiou H.Y., Chiang M.H., Lin L.J., Tai T.Y. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 1996, 16:504-510.
6. Chen C.J., Chen C.W., Wu M.M., Kuo T.L. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 1992, 66:888-892.
7. Chen C.J., Wu M.M., Lee S.S., Wang J.D., Cheng S.H., Wu H.Y. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arteriosclerosis 1988, 8:452-460.
8. Chen C.J., Chuang Y.C., Lin T.M., Wu H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res. 1985, 45:5895-5899.
9. Chen C.J., Hsu L.I., Wang C.H., Shih W.L., Hsu Y.H., Tseng M.P., Lin Y.C., Chou W.L., Chen C.Y., Lee C.Y., Wang L.H., Cheng Y.C., Chen C.L., Chen S.Y., Wang Y.H., Hsueh Y.M., Chiou H.Y., Wu M.M. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol. Appl. Pharmacol. 2005, 206:198-206.
10. Chen C.J., Hsueh Y.M., Lai M.S., Shyu M.P., Chen S.Y., Wu M.M., Kuo T.L., Tai T.Y. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 1995, 25:53-60.
11. Chen C.J., Kuo T.L., Wu M.M. Arsenic and cancers. Lancet 1988, 1:414-415.
12. Chen J.G., Chen Y.G., Zhou Y.S., Lin G.F., Li X.J., Jia C.G., Guo W.C., Du H., Lu H.C., Meng H., Zhang X.J., Golka K., Shen J.H. A follow-up study of mortality among the arseniasis patients exposed to indoor combustion of high arsenic coal in Southwest Guizhou Autonomous Prefecture, China. Int. Arch. Occup. Environ. Health 2007, 81:9-17.
13. Chen K.P., Wu H.Y., Wu T.C. Epidemiologie studies on blackfoot disease in Taiwan: 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Memoirs Coll. Med. Natl. Taiwan Univ. 1962, 8:115-129.
14. Chen Y., Graziano J.H., Parvez F., Liu M., Slavkovich V., Kalra T., Argos M., Islam T., Ahmed A., Rakibuz-Zaman M., Hasan R., Sarwar G., Levy D., van Geen A., Ahsan H. Arsenic exposure from drinking water and mortality from cardiovascular disease in Bangladesh: prospective cohort study. Br. Med. J. 2011, 342:d2431-d2442.
15. Chen Y.C., Amarasiriwardena C.J., Hsueh Y.M., Christiani D.C. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1427-1433.
16. Chen Y.C., Su H.J., Guo Y.L., Hsueh Y.M., Smith T.J., Ryan L.M., Lee M.S., Christiani D.C. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 2003, 14:303-310.
17. Chung C.J., Hsueh Y.M., Bai C.H., Huang Y.K., Huang Y.L., Yang M.H., Chen C.J. Polymorphisms in arsenic metabolism genes, urinary arsenic methylation profile and cancer. Cancer Causes Control 2009, 20:1653-1661.
18. Hindmarsh J.T. Caveats in hair analysis in chronic arsenic poisoning. Clin. Biochem. 2002, 35:1-11.
19. Hopenhayn-Rich C., Biggs M.L., Fuchs A., Bergoglio R., Tello E.E., Nicolli H., Smith A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996, 7:117-1124.
20. Hopenhayn-Rich C., Biggs M.L., Smith A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27:561-569.
21. Hsueh Y.M., Huang Y.L., Huang C.C., Wu W.L., Chen H.M., Yang M.H., Lue L.C., Chen C.J. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J. Toxicol. Environ. Health 1998, 54:431-444.
22. Huang Y.K., Huang Y.L., Hsueh Y.M., Wang J.T., Yang M.H., Chen C.J. Changes in urinary arsenic methylation profiles in a 15-year interval after cessation of arsenic ingestion in southwest Taiwan. Environ. Health Perspect. 2009, 117:1860-1866.
23. Huang Y.K., Huang Y.L., Hsueh Y.M., Yang M.H., Wu M.M., Chen S.Y., Hsu L.I., Chen C.J. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 2008, 19:829-839.
24. Hughes M.F. Biomarkers of exposure: a case study with inorganic arsenic. Environ. Health Perspect. 2006, 114:1790-1796.
25. Lai M.S., Hsueh Y.M., Chen C.J., Shyu M.P., Chen S.Y., Kuo T.L., Wu M.M., Tai T.Y. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am. J. Epidemiol. 1994, 139:484-492.
26. Lin S., Cullen W.R., Thomas D.J. Methylarsenicals and arsinothiols are potent inhibitors of mouse liver thioredoxin reductase. Chem. Res. Toxicol. 1999, 12:924-930.
27. Melkonian S., Argos M., Pierce B.L., Chen Y., Islam T., Ahmed A., Syed E.H., Parvez F., Graziano J., Rathouz P.J., Ahsan H. A prospective study of the synergistic effects of arsenic exposure and smoking, sun exposure, fertilizer use, and pesticide use on risk of premalignant skin lesions in Bangladeshi men. Am. J. Epidemiol. 2011, 173:183-191.
28. Morales K.H., Ryan L., Kuo T.L., Wu M.M., Chen C.J. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 2000, 108:655-661.
29. Nakadaira H., Endoh K., Katagiri M., Yamamoto M. Elevated mortality from lung cancer associated with arsenic exposure for a limited duration. J. Occup. Environ. Med. 2002, 44:291-299.
30. Pu Y.S., Yang S.M., Huang Y.K., Chung C.J., Huang S.K., Chiu A.W., Yang M.H., Chen C.J., Hsueh Y.M. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 2007, 218:99-106.
31. Smith A.H., Goycolea M., Haque R., Biggs M.L. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 1998, 147:660-669.
32. Smith A.H., Marshall G., Yuan Y., Liaw J., Ferreccio C., Steinmaus C. Evidence from Chile that arsenic in drinking water may increase mortality from pulmonary tuberculosis. Am. J. Epidemiol. 2011, 173:414-420.
33. Sohel N., Persson L.A., Rahman M., Streatfield P.K., Yunus M., Ekstrom E.C., Vahter M. Arsenic in drinking water and adult mortality: a population-based cohort study in rural Bangladesh. Epidemiology 2009, 20:824-830.
34. Steinmaus C., Yuan Y., Kalman D., Rey O.A., Skibola C.F., Dauphine D., Basu A., Porter K.E., Hubbard A., Bates M.N., Smith M.T., Smith A.H. Individual differences in arsenic metabolism and lung cancer in a case-control study in Cordoba, Argentina. Toxicol. Appl. Pharmacol. 2010, 247:138-145.
35. Tsai S.M., Wang T.N., Ko Y.C. Mortality for certain diseases in areas with high levels of arsenic in drinking water. Arch. Environ. Health 1999, 54:186-193.
36. Vahter M. Mechanisms of arsenic biotransformation. Toxicology 2002, 181-182:211-217.